320 related articles for article (PubMed ID: 30706844)
1. Diet, menopause and the risk of ovarian, endometrial and breast cancer.
Dunneram Y; Greenwood DC; Cade JE
Proc Nutr Soc; 2019 Aug; 78(3):438-448. PubMed ID: 30706844
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy and cancer.
Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
[TBL] [Abstract][Full Text] [Related]
3. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
Genazzani AR; Gadducci A; Gambacciani M
Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology of breast cancer.
Marchant DJ
Clin Obstet Gynecol; 1982 Jun; 25(2):387-92. PubMed ID: 7105514
[TBL] [Abstract][Full Text] [Related]
5. The prevention of breast cancer through reduced ovarian steroid exposure.
Spicer DV; Pike MC
Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
[TBL] [Abstract][Full Text] [Related]
6. Characterizing the trajectories of vasomotor symptoms across the menopausal transition.
Tepper PG; Brooks MM; Randolph JF; Crawford SL; El Khoudary SR; Gold EB; Lasley BL; Jones B; Joffe H; Hess R; Avis NE; Harlow S; McConnell DS; Bromberger JT; Zheng H; Ruppert K; Thurston RC
Menopause; 2016 Oct; 23(10):1067-74. PubMed ID: 27404029
[TBL] [Abstract][Full Text] [Related]
7. Decreased ovarian hormones during a soya diet: implications for breast cancer prevention.
Lu LJ; Anderson KE; Grady JJ; Kohen F; Nagamani M
Cancer Res; 2000 Aug; 60(15):4112-21. PubMed ID: 10945618
[TBL] [Abstract][Full Text] [Related]
8. Duration of ovarian hormone exposure and gynecological cancer risk in Korean women: the Korean Heart Study.
Jung KJ; Park C; Yun YD; Jee SH
Cancer Epidemiol; 2016 Apr; 41():1-7. PubMed ID: 26773407
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for breast cancer by oestrogen receptor status: a population-based case-control study.
Cooper JA; Rohan TE; Cant EL; Horsfall DJ; Tilley WD
Br J Cancer; 1989 Jan; 59(1):119-25. PubMed ID: 2757918
[TBL] [Abstract][Full Text] [Related]
10. Dietary factors and vasomotor symptoms in breast cancer survivors: the WHEL Study.
Gold EB; Flatt SW; Pierce JP; Bardwell WA; Hajek RA; Newman VA; Rock CL; Stefanick ML
Menopause; 2006; 13(3):423-33. PubMed ID: 16735939
[TBL] [Abstract][Full Text] [Related]
11. Estrogens in the causation of breast, endometrial and ovarian cancers - evidence and hypotheses from epidemiological findings.
Persson I
J Steroid Biochem Mol Biol; 2000 Nov; 74(5):357-64. PubMed ID: 11162945
[TBL] [Abstract][Full Text] [Related]
12. The relationship of longitudinal change in reproductive hormones and vasomotor symptoms during the menopausal transition.
Randolph JF; Sowers M; Bondarenko I; Gold EB; Greendale GA; Bromberger JT; Brockwell SE; Matthews KA
J Clin Endocrinol Metab; 2005 Nov; 90(11):6106-12. PubMed ID: 16144949
[TBL] [Abstract][Full Text] [Related]
13. Undetectable antimüllerian hormone levels and recovery of chemotherapy-induced ovarian failure in women with breast cancer on an oral aromatase inhibitor.
Dieudonné AS; Vandenberghe J; Geerts I; Billen J; Paridaens R; Wildiers H; Neven P
Menopause; 2011 Jul; 18(7):821-4. PubMed ID: 21326118
[TBL] [Abstract][Full Text] [Related]
14. Endogenous estrogens and the risk of breast, endometrial, and ovarian cancers.
Brown SB; Hankinson SE
Steroids; 2015 Jul; 99(Pt A):8-10. PubMed ID: 25555473
[TBL] [Abstract][Full Text] [Related]
15. Menopausal symptoms in epithelial ovarian cancer survivors: a GINECO VIVROVAIRE2 study.
Gernier F; Gompel A; Rousset-Jablonski C; Kalbacher E; Floquet A; Berton-Rigaud D; Tredan O; Alexandre J; Follana P; Zannetti A; Dohollou N; Grellard JM; Clarisse B; Licaj I; Ahmed-Lecheheb D; Fauvet R; Pautier P; Joly F
Gynecol Oncol; 2021 Dec; 163(3):598-604. PubMed ID: 34649724
[TBL] [Abstract][Full Text] [Related]
16. Hormones and cancer in humans.
Key TJ
Mutat Res; 1995 Dec; 333(1-2):59-67. PubMed ID: 8538637
[TBL] [Abstract][Full Text] [Related]
17. Protocol for systematic review and meta-analysis: hop (Humulus lupulus L.) for menopausal vasomotor symptoms.
Abdi F; Kazemi F; Ramezani Tehrani F; Roozbeh N
BMJ Open; 2016 Apr; 6(4):e010734. PubMed ID: 27105715
[TBL] [Abstract][Full Text] [Related]
18. Reproductive factors of ovarian and endometrial cancer risk in a high fertility population in Mexico.
Salazar-Martinez E; Lazcano-Ponce EC; Gonzalez Lira-Lira G; Escudero-De los Rios P; Salmeron-Castro J; Hernandez-Avila M
Cancer Res; 1999 Aug; 59(15):3658-62. PubMed ID: 10446978
[TBL] [Abstract][Full Text] [Related]
19. Hypertension and hormone-related neoplasms in women.
Soler M; Chatenoud L; Negri E; Parazzini F; Franceschi S; la Vecchia C
Hypertension; 1999 Aug; 34(2):320-5. PubMed ID: 10454461
[TBL] [Abstract][Full Text] [Related]
20. Cycle and hormone changes during perimenopause: the key role of ovarian function.
Burger HG; Hale GE; Dennerstein L; Robertson DM
Menopause; 2008; 15(4 Pt 1):603-12. PubMed ID: 18574431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
